CABALETTA BIO, INC. Shares Outstanding (Cover Page)
CABALETTA BIO, INC. (CABA) had Shares Outstanding (Cover Page) of 169.55 million shares as of 2026-08-07, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-07: Entity Common Stock, Shares Outstanding 169.55M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 163.05M shares.
- 2026-03-19: Entity Common Stock, Shares Outstanding 111.32M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 96.27M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 169.55M shares 10-Q · filed 2026-08-13 |
| 2026-05-07 | 163.05M shares 10-Q · filed 2026-05-14 |
| 2026-03-19 | 111.32M shares 10-K · filed 2026-03-23 |
| 2025-10-31 | 96.27M shares 10-Q · filed 2025-11-10 |
| 2025-08-01 | 91.47M shares 10-Q · filed 2025-08-07 |
| 2025-05-09 | 50.74M shares 10-Q · filed 2025-05-15 |
| 2025-03-27 | 50.74M shares 10-K · filed 2025-03-31 |
| 2024-11-08 | 48.88M shares 10-Q · filed 2024-11-14 |
| 2024-08-02 | 48.85M shares 10-Q · filed 2024-08-08 |
| 2024-05-10 | 48.28M shares 10-Q · filed 2024-05-15 |
| 2024-03-15 | 48.24M shares 10-K · filed 2024-03-21 |
| 2023-11-03 | 42.85M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 39.81M shares 10-Q · filed 2023-08-10 |
| 2023-05-05 | 31.36M shares 10-Q · filed 2023-05-11 |
| 2023-03-10 | 31.34M shares 10-K · filed 2023-03-16 |
| 2022-11-04 | 29.01M shares 10-Q · filed 2022-11-10 |
| 2022-08-05 | 29.01M shares 10-Q · filed 2022-08-11 |
| 2022-05-06 | 28.98M shares 10-Q · filed 2022-05-12 |
| 2022-03-10 | 28.98M shares 10-K · filed 2022-03-17 |
| 2021-10-29 | 28.33M shares 10-Q · filed 2021-11-01 |
| 2021-07-30 | 24.97M shares 10-Q · filed 2021-08-05 |
| 2021-04-29 | 24.93M shares 10-Q · filed 2021-05-03 |
| 2021-03-10 | 24.06M shares 10-K · filed 2021-03-16 |
| 2020-11-02 | 24.06M shares 10-Q · filed 2020-11-10 |
| 2020-07-29 | 24.04M shares 10-Q · filed 2020-08-06 |
| 2020-05-08 | 24.03M shares 10-Q · filed 2020-05-12 |
| 2020-03-20 | 24.03M shares 10-K · filed 2020-03-30 |
| 2019-12-05 | 24.03M shares 10-Q · filed 2019-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |